About Andrew DeSomma
Form D filings for K2 Biolabs from 2021 to 2023 list Andrew DeSomma as member of the board of directors.
Andrew DeSomma first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Andrew DeSomma in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Andrew DeSomma works with at each company, as listed on that company's latest Form D.
K2 Biolabs, Inc. · Form D, Aug 2, 2023
GF
Gerard Fleury
Member of the Board of Directors
CS
Clifford Stocks
Member of the Board of Directors
AS
Andrew Strong
Member of the Board of Directors
DC
Daniel Clark
Chief Financial Officer
KS
Kevin Slawin
Member of the Board of Directors
KJ
Kieron Jones
Executive officer and director